These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33773633)

  • 1. COVID-19 in France: challenges and opportunities.
    The Lancet Public Health
    Lancet Public Health; 2021 Apr; 6(4):e192. PubMed ID: 33773633
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening.
    Pagani G; Conti F; Giacomelli A; Bernacchia D; Rondanin R; Prina A; Scolari V; Gandolfi CE; Castaldi S; Marano G; Ottomano C; Boracchi P; Biganzoli E; Galli M
    J Infect; 2020 Dec; 81(6):e10-e12. PubMed ID: 32961253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 was already spreading in France in late December 2019.
    Deslandes A; Berti V; Tandjaoui-Lambotte Y; Alloui C; Carbonnelle E; Zahar JR; Brichler S; Cohen Y
    Int J Antimicrob Agents; 2020 Jun; 55(6):106006. PubMed ID: 32371096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.
    Gallais F; Velay A; Nazon C; Wendling MJ; Partisani M; Sibilia J; Candon S; Fafi-Kremer S
    Emerg Infect Dis; 2021 Jan; 27(1):113-21. PubMed ID: 33261718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New virus, new disease... and new challenges].
    Pallaro A
    Soins Pediatr Pueric; 2020; 41(317):12-15. PubMed ID: 33308795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First detection and genome sequencing of SARS-CoV-2 in an infected cat in France.
    Sailleau C; Dumarest M; Vanhomwegen J; Delaplace M; Caro V; Kwasiborski A; Hourdel V; Chevaillier P; Barbarino A; Comtet L; Pourquier P; Klonjkowski B; Manuguerra JC; Zientara S; Le Poder S
    Transbound Emerg Dis; 2020 Nov; 67(6):2324-2328. PubMed ID: 32500944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [COVID-19: what protection for hospital staff?].
    Pougnet R; Pougnet L; Dewitte JD
    Rev Infirm; 2020 Dec; 69(266):29. PubMed ID: 33308777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France.
    Dimeglio C; Loubes JM; Deporte B; Dubois M; Latour J; Mansuy JM; Izopet J
    J Infect; 2020 Aug; 81(2):318-356. PubMed ID: 32360497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes about COVID-19 Lockdown among General Population, France, March 2020.
    Peretti-Watel P; Seror V; Cortaredona S; Launay O; Raude J; Verger P; Beck F; Legleye S; L'Haridon O; Ward J; ; Longitudinale E; ;
    Emerg Infect Dis; 2021 Jan; 27(1):301-3. PubMed ID: 33183493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Were protective procedures against SARS-CoV-2 effective in an orthopaedic and trauma centre during the lockdown period? A retrospective study.
    Bouche PA; Valteau B; Dumaine V; Lang E; Michel K; Eyrolle L; Auberger G; Anract P; Hamadouche M
    Int Orthop; 2020 Dec; 44(12):2493-2498. PubMed ID: 32676776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the determinants of acceptance of COVID-19 vaccines: a challenge in a fast-moving situation.
    Verger P; Peretti-Watel P
    Lancet Public Health; 2021 Apr; 6(4):e195-e196. PubMed ID: 33556329
    [No Abstract]   [Full Text] [Related]  

  • 13. Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France).
    Tanga V; Leroy S; Fayada J; Hamila M; Allegra M; Messaoudi Z; Bonnetaud C; Lespinet V; Bordone O; Washetine K; Griffonnet J; Maniel C; Philibert L; Selva E; Benzaquen J; Ilie M; Long E; Lassalle S; Lantéri E; Marquette CH; Hofman V; Hofman P
    Biopreserv Biobank; 2020 Dec; 18(6):517-524. PubMed ID: 33175565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19 on pediatric clinical research in France.
    Flamein F; Gottrand F; Patel ML; Hankard R
    CMAJ; 2020 May; 192(21):E589. PubMed ID: 32575064
    [No Abstract]   [Full Text] [Related]  

  • 15. Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.
    Péré H; Mboumba Bouassa RS; Tonen-Wolyec S; Podglajen I; Veyer D; Bélec L
    J Virol Methods; 2021 Apr; 290():114067. PubMed ID: 33476707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
    Ouldali N; Pouletty M; Mariani P; Beyler C; Blachier A; Bonacorsi S; Danis K; Chomton M; Maurice L; Le Bourgeois F; Caseris M; Gaschignard J; Poline J; Cohen R; Titomanlio L; Faye A; Melki I; Meinzer U
    Lancet Child Adolesc Health; 2020 Sep; 4(9):662-668. PubMed ID: 32622376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study.
    Alexandre J; Cracowski JL
    Fundam Clin Pharmacol; 2021 Feb; 35(1):192-193. PubMed ID: 33290594
    [No Abstract]   [Full Text] [Related]  

  • 18. [Once a caregiver, always a caregiver].
    Bourgeois A; Carre I; Hamel C; Lecland P
    Rev Infirm; 2020 Dec; 69(266):26-28. PubMed ID: 33308776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020.
    Lechien JR; Chetrit A; Chekkoury-Idrissi Y; Distinguin L; Circiu M; Saussez S; Berradja N; Edjlali M; Hans S; Carlier R
    Emerg Infect Dis; 2020 Sep; 26(9):2270-1. PubMed ID: 32491984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the timing and adherence to face mask use on the course of the COVID-19 epidemic in France.
    Hoertel N; Blachier M; Sánchez-Rico M; Limosin F; Leleu H
    J Travel Med; 2021 Feb; 28(2):. PubMed ID: 33506243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.